PMVP — PMV Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $74.19m
- -$68.09m
- 29
- 51
- 48
- 37
Annual cashflow statement for PMV Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -34.4 | -57.8 | -73.3 | -69 | -58.7 |
| Depreciation | |||||
| Non-Cash Items | 2.23 | 6.84 | 9.81 | 6.62 | 7.88 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.845 | 4.12 | -0.568 | 5.43 | -1.59 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -32.7 | -46.6 | -63.8 | -55.7 | -51.3 |
| Capital Expenditures | -0.148 | -1.35 | -7.98 | -0.962 | -0.655 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 28.1 | -142 | 6.62 | -49.6 | 54 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 27.9 | -144 | -1.37 | -50.5 | 53.4 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 293 | 2.02 | 0.958 | 35.6 | 0.313 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 288 | -188 | -64.2 | -70.6 | 2.35 |